Skip to content

Salt-Partitioned Moxibustion at CV8 Modulates Gut Microbiota to Enhance Stroke Recovery: A dose-ranging, single-blind, randomized controlled trial

Clinical Observation of Different Moxibustion Dosages for Convalescent Stroke Patients with Qi Deficiency and Blood Stasis Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001695
Enrollment
Unknown
Registered
2026-07-06
Start date
2024-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

non-moxibustion control group:0 cone/session, once every other day, for a total of 2 weeks
mild-moxibustion control group:2 cones/session, once every other day, for a total of 2 weeks
high-dose moxibustion group :3 cones/session, once every other day, for a total of 2 weeks

Sponsors

Shenzhen Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the Western medical diagnostic criteria for ischemic stroke and be in the convalescent stage of cerebrovascular disease (refer to Key Points for Diagnosis of Various Cerebrovascular Diseases, 1997). (2) Meet the traditional Chinese medicine (TCM) diagnostic criteria for apoplexy, with syndrome differentiation of qi deficiency and blood stasis (refer to Criteria for Diagnosis and Therapeutic Effect Evaluation of Apoplexy, drafted and formulated by the Scientific Research Cooperative Group for Encephalopathy Emergency, State Administration of Traditional Chinese Medicine, 1995). (3) Have stable vital signs and be able to cooperate with treatment, examinations and follow-up. (4) Aged 40–80 years, gender unlimited; conscious, able to communicate verbally or understand daily questions to complete clinical efficacy evaluation. (5) Participate in the study voluntarily, with informed consent signed by the patient or their legal guardian.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardiac diseases, infectious diseases, or complicated with cardiac, hepatic or renal failure, malignant tumors, and gastrointestinal bleeding. (2) Patients with limb disability, organ defect or deformity caused by craniocerebral trauma, intracranial tumor, intracranial infection, cerebral demyelinating lesions or other etiologies. (3) Pregnant or lactating women. (4) Patients currently participating in other clinical trials that may affect the evaluation of the present study results. (5) Patients with sensory disturbance or cognitive impairment induced by stroke or other causes.

Design outcomes

Primary

MeasureTime frame
NIHSS ;

Secondary

MeasureTime frame
Barthel ;TCM Syndrome Scale;Gut microbiota analysis parameters;

Countries

China

Contacts

Public ContactYanhua Gou

Shenzhen Traditional Chinese Medicine Hospital

13632951682@163.com136 3295 1682

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026